Out of the Box Coaching and
Breakthroughs with the Enneagram, Mary R. Bast, Ph.D. 
Copyright © 1999. All rights reserved. Revised: January 15, 2012
  


Click on "Contact" below left to send email
   

 

 

 

 


Follow My Blogs:
 
Self-Coaching Tips    ► Coach Mentor


A Strange Blessing

"...a life-threatening disease like cancer is a strange blessing that casts our life and purpose in sharp relief," wrote Hamilton Jordan in No Such Thing as a Bad Day. "Some cancer patients allow cancer to dominate and define their lives. They cut themselves off from their families and friends, throw in the towel emotionally, expect the worst, and fulfill that expectation. But there are many, many more who use their illness to find new meaning in their lives. And these are the patients who beat cancer against all odds or greatly exceed their prognosis or medical expectation."

From his own experience, and from his research, Jordan developed the strong belief that responses to the words "You have cancer" – emotional, intellectual, and physical – have a lot to do with survival and with quality of life. This is not to suggest that the immediate reaction will be "positive thinking." After surviving three different kinds of cancer, he challenged himself to never forget his own "raw fear," because he wanted to hold onto the sense of purpose that cancer brought to him, "the ironic blessing."

"I know many strong and intelligent people," he observed, "who are so devastated by their diagnosis of cancer they are paralyzed with fear, fail to take charge of their lives and medical options, and do not take advantage of their greatest resources:

  • the ability to be an active partner in the medical decisions that will determine whether they will live or die, and

  • the will to live, which now has been demonstrated scientifically to have an impact on the course of disease generally and cancer specifically."

Note: Jordon died on May 20, 2008, aged 63, from peritoneal mesothelioma. Earlier in his life he had survived non-Hodgkin lymphoma, melanoma, and prostate cancer.